Impact of Peritoneal Dialysis Treatment on Arterial Stiffness and Vascular Changes in Diabetic Type 2 and Nondiabetic Patients with End-Stage Renal Disease
Figure 1
Endothelin-1 serum levels in patients with and without DM type 2 at baseline and after 12 months on peritoneal dialysis.